Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G8UA
|
|||
Former ID |
DNC010900
|
|||
Drug Name |
(R)-2-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol
|
|||
Synonyms |
CHEMBL1084971; (R)-2-(2-phenyl-2-(piperazin-1-yl)ethyl)phenol
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H22N2O
|
|||
Canonical SMILES |
C1CN(CCN1)C(CC2=CC=CC=C2O)C3=CC=CC=C3
|
|||
InChI |
1S/C18H22N2O/c21-18-9-5-4-8-16(18)14-17(15-6-2-1-3-7-15)20-12-10-19-11-13-20/h1-9,17,19,21H,10-14H2/t17-/m1/s1
|
|||
InChIKey |
SBKGLFTUHHUCII-QGZVFWFLSA-N
|
|||
CAS Number |
CAS 1238669-95-8
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reduc... Bioorg Med Chem Lett. 2010 Jun 15;20(12):3788-92. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.